21 COVID-19 vaccines enter clinical trials in China: official
People's Daily Online
(Xinhua) 13:49, June 07, 2021
BEIJING, June 7 (Xinhua) -- China has witnessed 21 COVID-19 vaccines enter clinical trials, an official with the National Health Commission (NHC) said Sunday.
So far, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, according to Zeng Yixin, deputy head of the NHC.
A total of eight COVID-19 vaccines have been approved for phase III clinical trial overseas, and one messenger RNA (mRNA) COVID-19 vaccine met the ethical requirements for phase III clinical trial overseas, Zeng said.
|
NEWSLETTER
|
| Join the GlobalSecurity.org mailing list |
|
|
|
